Viral mechanisms of adipose dysfunction: lessons from HIV-1 Vpr

Adipocyte

Volumn 4, Issue 1, 2015, Pages 55-59

  Agarwal, N ^a   Balasubramanyam, Ashok ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

Author keywords

Cell cycle arrest; Fat oxidation; Glucocorticoid receptor (GR); Hepatosteatosis; HIV 1; Insulin resistance; Lipodystrophy; Lipolysis; Metabolic disorder; Peroxisome proliferator activated receptor (PPAR); Viral infection; Vpr

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADIPONECTIN; GLUCOCORTICOID; HIV 1 VIRAL PROTEIN; LIPOPROTEIN LIPASE; LIVER X RECEPTOR ALPHA; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VPR PROTEIN;

ARTICLE; DIABETES MELLITUS; DYSLIPIDEMIA; FATTY LIVER; GENE EXPRESSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INSULIN RESISTANCE; LIPODYSTROPHY; LIPOLYSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PLEIOTROPY; VIRUS INFECTION; WHITE ADIPOSE TISSUE;

EID: 85050578298     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.4161/adip.29852     Document Type: Article

References (53)

1. Hegele RA, Joy TR, Al-Attar SA, Rutt BK. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 2007; 48: 1433-44; PMID: 17374881; http: //dx. doi. org/10. 1194/jlr. R700004-JLR200
2. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 2010; 207: 245-55; PMID: 20870709; http: //dx. doi. org/10. 1677/JOE-10-0272
3. Shevitz A, Wanke CA, Falutz J, Kotler DP. Clinical perspectives on HIV-associated lipodystrophy syndrome: an update. Aids 2001; 15: 1917-30; PMID: 11600819; http: //dx. doi. org/10. 1097/00002030-200110190-00003
4. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 1998; 351: 867-70; PMID: 9525364; http: //dx. doi. org/ 10. 1016/S0140-6736(97)11443-X
5. Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir Ther 2004; 9: 161-77; PMID: 15134178
6. Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepcion ML, Alegre M, Domingo JC, Villarroya F. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1/HAART-associated lipodystrophy. Antivir Ther 2006; 11: 729-40; PMID: 17310817
7. Guallar JP, Gallego-Escuredo JM, Domingo JC, Alegre M, Fontdevila J, Martinez E, Hammond EL, Domingo P, Giralt M, Villarroya F. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy. Aids 2008; 22: 575-84; PMID: 18316998; http: //dx. doi. org/ 10. 1097/QAD. 0b013e3282f56b40
8. Milinkovic A. HIV-associated lipodystrophy syndrome. Coll Antropol 2006; 30 Suppl 2: 59-62; PMID: 17508476
9. Balasubramanyam A, Sekhar RV, Jahoor F, Jones PH, Pownall HJ. Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'. Curr Opin Lipidol 2004; 15: 59-67; PMID: 15166810; http: //dx. doi. org/ 10. 1097/00041433-200402000-00011
10. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989; 86: 27-31; PMID: 2910092; http: //dx. doi. org/10. 1016/0002-9343(89)90225-8
11. Visnegarwala F, Raghavan SS, Mullin CM, Bartsch G, Wang J, Kotler D, Gibert CL, Shlay J, Grunfeld C, Carr A, et al. Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons. Am J Clin Nutr 2005; 82: 850-6; PMID: 16210716
12. Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, Saag M, Scherzer R, Shlipak M, Tien P, et al. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005; 40: 121-31; PMID: 16186728; http: //dx. doi. org/10. 1097/01. qai. 0000182230. 47819. aa
13. Sekhar RV, Jahoor F, White AC, Pownall HJ, Visnegarwala F, Rodriguez-Barradas MC, Sharma M, Reeds PJ, Balasubramanyam A. Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab 2002; 283: E332-7; PMID: 12110539
14. Reeds DN, Mittendorfer B, Patterson BW, Powderly WG, Yarasheski KE, Klein S. Alterations in lipid kinetics in men with HIV-dyslipidemia. Am J Physiol Endocrinol Metab 2003; 285: E490-7; PMID: 12746213
15. Hadigan C, Borgonha S, Rabe J, Young V, Grinspoon S. Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy. Metabolism 2002; 51: 1143-7; PMID: 12200758; http: //dx. doi. org/10. 1053/meta. 2002. 34704
16. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 2009; 50: 3-21; PMID: 18952573; http: //dx. doi. org/ 10. 1194/jlr. R800031-JLR200
17. Zimmermann R, Lass A, Haemmerle G, Zechner R. Fate of fat: the role of adipose triglyceride lipase in lipolysis. Biochim Biophys Acta 2009; 1791: 494-500; PMID: 19010445; http: //dx. doi. org/10. 1016/j. bbalip. 2008. 10. 005
18. Chow DC, Tasaki A, Ono J, Shiramizu B, Souza SA. Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome. Biologics 2008; 2: 917-21; PMID: 19707470
19. Shen WJ, Yu Z, Patel S, Jue D, Liu LF, Kraemer FB. Hormone-sensitive lipase modulates adipose metabolism through PPARgamma. Biochim Biophys Acta; 1811: 9-16; PMID: 20950707
20. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr 2007; 27: 79-101; PMID: 17313320; http: // dx. doi. org/10. 1146/annurev. nutr. 27. 061406. 093734
21. Domingo P, Matias-Guiu X, Pujol RM, Francia E, Lagarda E, Sambeat MA, Sharma M, Reeds PJ, Balasubramanyam A. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. Aids 1999; 13: 2261-7; PMID: 10563711; http: //dx. doi. org/10. 1097/00002030-199911120-00008
22. Domingo P, Vidal F, Domingo JC, Veloso S, Sambeat MA, Torres F, Sirvent JJ, Vendrell J, Matias-Guiu X, Richart C, et al. Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis. Eur J Clin Invest 2005; 35: 771-80; PMID: 16313254; http: //dx. doi. org/10. 1111/j. 1365-2362. 2005. 01576. x
23. Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H, Girard PM, Levan P, Rozenbaum W, Lombés A, et al. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir Ther 2004; 9: 555-64; PMID: 15456087
24. Torriani M, Fitch K, Stavrou E, BredellaMA, LimR, Sass CA, Cypess AM, Grinspoon S. Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome. J Clin EndocrinolMetab 2012; 97: E602-7; PMID: 22259052; http: //dx. doi. org/ 10. 1210/jc. 2011-2951
25. Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 1999; 189: 51-62; PMID: 9874563; http: //dx. doi. org/10. 1084/jem. 189. 1. 51
26. Kino T, Gragerov A, Slobodskaya O, Tsopanomichalou M, Chrousos GP, Pavlakis GN. Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J Virol 2002; 76: 9724-34; PMID: 12208951; http: //dx. doi. org/10. 1128/JVI. 76. 19. 9724-9734. 2002
27. Shrivastav S, Kino T, Cunningham T, Ichijo T, Schubert U, Heinklein P, Chrousos GP, Kopp JB. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy. Mol Endocrinol 2008; 22: 234-47; PMID: 17932108; http: // dx. doi. org/10. 1210/me. 2007-0124
28. Poon B, Grovit-Ferbas K, Stewart SA, Chen IS. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 1998; 281: 266-9; PMID: 9657723; http: //dx. doi. org/10. 1126/science. 281. 5374. 266
29. Sherman MP, Schubert U, Williams SA, de Noronha CM, Kreisberg JF, Henklein P, Greene WC. HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology 2002; 302: 95-105; PMID: 12429519; http: //dx. doi. org/ 10. 1006/viro. 2002. 1576
30. Agarwal N, Iyer D, Patel SG, Sekhar RV, Phillips TM, Schubert U, Oplt T, Buras ED, Samson SL, Couturier J, et al. HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR Co-regulation. Sci Transl Med 2013; 5: 213ra164; PMID: 24285483; http: //dx. doi. org/10. 1126/scitranslmed. 3007148
31. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995; 27: 435-8; PMID: 8519504; http: //dx. doi. org/10. 3109/ 07853899509002451
32. Chapman K, Holmes M, Seckl J. 11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev 2013; 93: 1139-206; PMID: 23899562; http: //dx. doi. org/10. 1152/physrev. 00020. 2012
33. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, Ferrante AWJr. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010; 120: 3466-79; PMID: 20877011; http: //dx. doi. org/10. 1172/JCI42845
34. Gallego-Escuredo J, Villarroya J, Domingo P, Targarona E, Alegre M Domingo JC, Villarroya F, Giralt M. Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy. JAIDS 2013; 64: 142-8; PMID: 23714743
35. Klöting N, Berthold S, Kovacs P, Schon MR, Fasshauer M, Ruschke K, Stumvoll M, Blüher M. MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 2009; 4(3): e4699; PMID: 19259271; http: //dx. doi. org/10. 1371/journal. pone. 0004699
36. Ortega FJ, Moreno-Navarrete JM, Ribas V, Esteve E, Rodriguez-Hermosa JI, Ruiz B, Peral B, Ricart W, Zorzano A, Fernández-Real JM. Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat. Obesity (Silver Spring) 2009; 17: 2134-41; PMID: 19360007; http: //dx. doi. org/ 10. 1038/oby. 2009. 110
37. Ortega FJ, Moreno-Navarrete JM, Pardo G, Sabater M, Hummel M, Ferrer A, Rodriguez-Hermosa JI, Ruiz B, Ricart W, Peral B, et al. MiRNA expression profi le of human subcutaneous adipose and during adipocyte differentiation. PLoS One 2010; 5(2): e9022; PMID: 20126310; http: //dx. doi. org/10. 1371/journal. pone. 0009022
38. Hadigan C, Liebau J, Andersen R, Holalkere NS, Sahani DV. Magnetic resonance spectroscopy of hepatic lipid content and associated risk factors in HIV infection. J Acquir Immune Defic Syndr 2007; 46: 312-7; PMID: 17721396; http: //dx. doi. org/10. 1097/ QAI. 0b013e3181568cc2
39. Lemoine M, Serfaty L, Capeau J. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. Curr Opin Infect Dis 2012; 25: 10-6; PMID: 22183113; http: //dx. doi. org/10. 1097/QCO. 0b013e32834ef599
40. Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE. HIV mono-infection is associated with FIB-4-A noninvasive index of liver fibrosis-in women. Clin Infect Dis 2011; 52: 674-80; PMID: 21248367; http: // dx. doi. org/10. 1093/cid/ciq199
41. Guaraldi G, Squillace N, Stentarelli C, Orlando G, D'Amico R, Ligabue G, Fiocchi F, Zona S, Loria P, Esposito R, et al. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Clin Infect Dis 2008; 47: 250-7; PMID: 18532884; http: //dx. doi. org/10. 1086/589294
42. Crum-Cianflone N, Dilay A, Collins G, Asher D, Campin R, Medina S, Goodman Z, Parker R, Lifson A, Capozza T, et al. Nonalcoholic fatty liver disease among HIV-infected persons. J Acquir Immune Defic Syndr 2009; 50: 464-73; PMID: 19225402; http: //dx. doi. org/10. 1097/QAI. 0b013e318198a88a
43. Mendeni M, Foca E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis 2011; 52: 1164-73; PMID: 21467023; http: //dx. doi. org/10. 1093/cid/cir071
44. Shrivastav S, Zhang L, Okamoto K, Lee H, Lagranha C, Abe Y, Balasubramanyam A, Lopaschuk GD, Kino T, Kopp JB. HIV-1 Vpr enhances PPARb/d-mediated transcription, increases PDK4 expression, and reduces PDC activity. Mol Endocrinol. 2013; 27: 1564-76; PMID: 23842279
45. Jacobson DL, Knox T, Spiegelman D, Skinner S, Gorbach S, Wanke C. Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clin Infect Dis 2005; 40: 1837-45; PMID: 15909274; http: //dx. doi. org/ 10. 1086/430379
46. Andany N, Raboud JM, Walmsley S, Diong C, Rourke SB, Rueda S, Rachlis A, Wobeser W, Macarthur RD, Binder L, et al. Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada. HIV Clin Trials 2011; 12: 89-103; PMID: 21498152; http: //dx. doi. org/ 10. 1310/hct1202-89
47. Heath KV, Chan KJ, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS. Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy. Int J Epidemiol 2002; 31: 1016-20; PMID: 12435777; http: //dx. doi. org/10. 1093/ije/31. 5. 1016
48. Galli M, Veglia F, Angarano G, Santambrogio S, Meneghini E, Gritti F, Cargnel A, Mazzotta F, Lazzarin A. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003; 34: 58-61; PMID: 14501794; http: //dx. doi. org/10. 1097/ 00126334-200309010-00008
49. McComsey G, Rightmire A, Wirtz V, Yang R, Mathew M, McGrath D. Changes in body composition with ritonavir-boosted and unboosted atazanavir treatment in combination with Lamivudine and Stavudine: a 96-week randomized, controlled study. Clin Infect Dis 2009; 48: 1323-6; PMID: 19302017; http: //dx. doi. org/ 10. 1086/597776
50. Gasparotto AS, Sprinz E, Lazzaretti RK, Kuhmmer R, Silveira JM, Basso RP, Pinheiro CA, Silveira MF, Ribeiro JP, Mattevi VS. Genetic polymorphisms in estrogen receptors and sexual dimorphism in fat redistribution in HIV-infected patients on HAART. Aids 2012; 26: 19-26; PMID: 22011627; http: //dx. doi. org/ 10. 1097/QAD. 0b013e32834db3ac
51. Cabrero E, Griffa L, Burgos A. Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions. AIDS Patient Care STDS 2010; 24: 5-13; PMID: 20095903; http: // dx. doi. org/10. 1089/apc. 2009. 0191
52. Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in women with HIV infection. J Acquir Immune Defic Syndr 2006; 42: 562-71; PMID: 16837863; http: //dx. doi. org/ 10. 1097/01. qai. 0000229996. 75116. da
53. Caron-Debarle M, Lagathu C, Boccara F, Vigouroux C, Capeau J. HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol Med 2010; 16: 218-29; PMID: 20400373; http: //dx. doi. org/ 10. 1016/j. molmed. 2010. 03. 002